Vise Technologies, Inc. Astrazeneca PLC Transaction History
Vise Technologies, Inc.
- $2.32 Billion
- Q2 2025
A detailed history of Vise Technologies, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Vise Technologies, Inc. holds 29,648 shares of AZN stock, worth $2.49 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
29,648
Previous 21,981
34.88%
Holding current value
$2.49 Million
Previous $1.44 Million
43.82%
% of portfolio
0.09%
Previous 0.12%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,444Shares Held
497MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...